155 related articles for article (PubMed ID: 35571403)
1. Bromodomain-containing protein 4 activates cardiotrophin-like cytokine factor 1, an unfavorable prognostic biomarker, and promotes glioblastoma
Shen SH; Guo JF; Huang J; Zhang Q; Cui Y
Ann Transl Med; 2022 Apr; 10(8):475. PubMed ID: 35571403
[TBL] [Abstract][Full Text] [Related]
2. Bromodomain containing 4 transcriptionally activated Deltex E3 ubiquitin ligase 2 contributes to glioma progression and predicts an unfavorable prognosis.
Wu S; Shen SH; Lu F; Zheng P; Lin K; Liao J; Jiang X; Zeng G; Wei D
Ann Transl Med; 2022 Mar; 10(6):313. PubMed ID: 35434025
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
Song ZB; Yang HP; Xu AQ; Zhan ZM; Song Y; Li ZY
Chin Med J (Engl); 2020 Mar; 133(6):670-678. PubMed ID: 32197031
[TBL] [Abstract][Full Text] [Related]
4. CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma.
Jiang Y; Ji Q; Long X; Wang P; Tu Z; Zhang X; Zhu X; Huang K; Li J
Front Immunol; 2022; 13():810832. PubMed ID: 35265072
[TBL] [Abstract][Full Text] [Related]
5. MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma.
Li G; Ma L; Feng C; Yin H; Bao J; Wu D; Zhang Z; Li X; Li Z; Yang C; Wang H; Fang F; Hu X; Li M; Xu L; Xu Y; Liang H; Yang T; Wang J; Pan J
BMC Cancer; 2024 Feb; 24(1):220. PubMed ID: 38365636
[TBL] [Abstract][Full Text] [Related]
6. KIF18A interacts with PPP1CA to promote the malignant development of glioblastoma.
Yang J; Zhang Q; Yang Z; Shu J; Zhang L; Yao Y; Wang X; Liu X
Exp Ther Med; 2023 Apr; 25(4):154. PubMed ID: 36911368
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylation-induced prognostic marker zinc finger DHHC-type palmitoyltransferase 12 contributes to glioblastoma progression.
Lu F; Shen SH; Wu S; Zheng P; Lin K; Liao J; Jiang X; Zeng G; Wei D
Ann Transl Med; 2022 Mar; 10(6):334. PubMed ID: 35434031
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of
Wang H; Wang X; Xu L; Zhang J; Cao H
Front Oncol; 2021; 11():551160. PubMed ID: 33959491
[No Abstract] [Full Text] [Related]
9. miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma.
Zeng A; Yin J; Li Y; Li R; Wang Z; Zhou X; Jin X; Shen F; Yan W; You Y
Cell Death Dis; 2018 Mar; 9(3):394. PubMed ID: 29531296
[TBL] [Abstract][Full Text] [Related]
10. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
13. Cardiotrophin-Like Cytokine Factor 1 Exhibits a Myeloid-Biased Hematopoietic-Stimulating Function.
Pasquin S; Tormo A; Moreau J; Laplante V; Sharma M; Gauchat JF; Rafei M
Front Immunol; 2019; 10():2133. PubMed ID: 31552057
[TBL] [Abstract][Full Text] [Related]
14. RBM8A Promotes Glioblastoma Growth and Invasion Through the Notch/STAT3 Pathway.
Lin Y; Wei L; Hu B; Zhang J; Wei J; Qian Z; Zou D
Front Oncol; 2021; 11():736941. PubMed ID: 34804926
[TBL] [Abstract][Full Text] [Related]
15. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
[TBL] [Abstract][Full Text] [Related]
16. EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma.
Zhou Y; Xiao D; Jiang X; Nie C
J Transl Med; 2023 Jan; 21(1):28. PubMed ID: 36647156
[TBL] [Abstract][Full Text] [Related]
17. Liuwei Dihuang Pill () Treats Postmenopausal Osteoporosis with Shen (Kidney) Yin Deficiency via Janus Kinase/Signal Transducer and Activator of Transcription Signal Pathway by Up-regulating Cardiotrophin-Like Cytokine Factor 1 Expression.
Ge JR; Xie LH; Chen J; Li SQ; Xu HJ; Lai YL; Qiu LL; Ni CB
Chin J Integr Med; 2018 Jun; 24(6):415-422. PubMed ID: 28028720
[TBL] [Abstract][Full Text] [Related]
18. Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway.
Wen N; Guo B; Zheng H; Xu L; Liang H; Wang Q; Wang D; Chen X; Zhang S; Li Y; Zhang L
Int J Oncol; 2019 Oct; 55(4):879-895. PubMed ID: 31485609
[TBL] [Abstract][Full Text] [Related]
19. CircPITX1 Regulates Proliferation, Angiogenesis, Migration, Invasion, and Cell Cycle of Human Glioblastoma Cells by Targeting miR-584-5p/KPNB1 Axis.
Cao Y; Wang F; Chen Y; Wang Y; Song H; Long J
J Mol Neurosci; 2021 Aug; 71(8):1683-1695. PubMed ID: 33763840
[TBL] [Abstract][Full Text] [Related]
20. KDELR2 is an unfavorable prognostic biomarker and regulates CCND1 to promote tumor progression in glioma.
Mao H; Nian J; Wang Z; Li X; Huang C
Pathol Res Pract; 2020 Jul; 216(7):152996. PubMed ID: 32534703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]